A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Filamon LTD
University Hospital Heidelberg
Hoosier Cancer Research Network
M.D. Anderson Cancer Center
Thomas Jefferson University
Shanghai Chest Hospital
Essen Biotech
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Novartis
Tango Therapeutics, Inc.
NRG Oncology
NRG Oncology
Eli Lilly and Company
Var2 Pharmaceuticals
Stanford University
Mayo Clinic
University of Washington
City of Hope Medical Center
National Cancer Institute (NCI)
Sun Yat-sen University
Dana-Farber Cancer Institute
University of Kentucky
Mayo Clinic
Eli Lilly and Company
National Cancer Institute (NCI)
Virginia Commonwealth University
Maastricht Radiation Oncology
Latin American Cooperative Oncology Group
Sun Yat-sen University
LigaChem Biosciences, Inc.
Alpha Biopharma (Jiangsu) Co., Ltd.
Washington University School of Medicine
Institut Cancerologie de l'Ouest
Incyte Corporation
Jonsson Comprehensive Cancer Center
Apollomics Inc.
NRG Oncology
City of Hope Medical Center
Columbia University
Thomas Jefferson University
Fundación GECP
Institut du Cancer de Montpellier - Val d'Aurelle
Stanford University
Cedars-Sinai Medical Center
Blueprint Medicines Corporation
ABM Therapeutics Corporation